OncoRes Medical is revolutionizing the standard of care in breast cancer surgery with its innovative intraoperative imaging tool. The technology translates the surgeon's sense of touch into a microscale image, thereby enhancing surgical accuracy and reducing complication rates. Established in 2016, OncoRes has garnered support from the Medical Research Commercialisation Fund and collaborates with esteemed researchers at the University of Western Australia and the Harry Perkins Institute of Medical Research, as well as breast cancer surgeons from the Western Australian Department of Health. Specializing in the Biotechnology and Health Care sectors, the company is headquartered in Australia. Its most recent $3.00M grant investment from the Cooperative Research Centre Projects was secured on 18 May 2022. For more information, visit www.oncoresmedical.com or contact them at [email protected].
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | $9.50M | 3 | Future of Healthcare Fund - Australian Unity | 18 May 2022 |
Grant | $3.00M | 1 | Cooperative Research Centre Projects | 18 May 2022 |
Grant | $150.00K | 1 | Government of Western Australia | 22 Jan 2021 |
Grant | $25.00K | 1 | 03 Jul 2019 | |
Non Equity Assistance | Unknown | 1 | 13 Dec 2018 |
No recent news or press coverage available for OncoRes Medical.